Fig. 4From: Relationship between serum lipid levels and the immune microenvironment in breast cancer patients: a retrospective studyRecurrence-free survival (RFS) using Kaplan-Meier method in postmenopausal hormone receptor (HR)-postive/human epidermal growth factor receptor 2 (HER2)-negative patients treated for dyslipidemia based on control of serum lipid levels. Patients without adjuvant endocrine therapy (a) and patients with adjuvant endocrine therapy (b)Back to article page